Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial)

Blood (2018) 132 (Supplement 1): 1019.

https://doi.org/10.1182/blood-2018-99-113340

Published: 2018

Journal Articles

Salvage Therapy with Bortezomib and Dexamethasone in Elderly Patients with Relapsed Refractory Multiple Myeloma

Roberto Castelli, Prof, Paolo Gallipoli, PhD, Antonio Gidaro, Wu Maddalena, Massimo Arquati, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2015) 126 (23): 5378.

https://doi.org/10.1182/blood.V126.23.5378.5378

Published: 2015

Journal Articles

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Blood (2014) 124 (21): 320.

https://doi.org/10.1182/blood.V124.21.320.320

Published: 2014

Journal Articles

Fatigue Is the Major Aspect Compromising Health-Related Quality of Life of Chronic Myeloid Leukemia Patients Receiving Long-Term Imatinib Therapy

Blood (2012) 120 (21): 4234.

https://doi.org/10.1182/blood.V120.21.4234.4234

Published: 2012

Journal Articles

Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Patients in Early Stage Disease,

Sonia Fabris, PhD, Mirjam Hoxha, PhD, Luca Agnelli, PhD, Laura Dioni, PhD, Valentina Bollati, PhD, Gabriella Ciceri, Laura Mosca, PhD, Marzia Barbieri, PhD, Giovanna Cutrona, PhD, Serena Matis, PhD, Massimo Gentile, MD, Giorgio Lambertenghi Deliliers, MD, Agostino Cortelezzi, MD, Fortunato Morabito, MD, Manlio Ferrarini, MD, Andrea Baccarelli, PhD, Antonino Neri, MD, Pier Alberto Bertazzi, MD

Blood (2011) 118 (21): 3890.

https://doi.org/10.1182/blood.V118.21.3890.3890

Published: 2011

Journal Articles

Investigating Personal and Treatment Related Factors Associated with Adherence Behavior in Patients with Chronic Myeloid Leukemia Receiving Long Term Imatinib Therapy

Fabio Efficace, PhD, Michele Baccarani, MD, Massimo Breccia, Giuliana Alimena, Gianantonio Rosti, MD, Francesco Cottone, PhD, Fausto Castagnetti, Giorgio Lambertenghi Deliliers, MD, Antonella Russo Rossi, Simonetta Pardini, Filippo Gherlinzoni, MD, Marzia Salvucci, Mario Tiribelli, Marco Vignetti, Franco Mandelli, MD

Blood (2011) 118 (21): 1026.

https://doi.org/10.1182/blood.V118.21.1026.1026

Published: 2011

Journal Articles

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Blood (2011) 118 (17): 4554–4560.

https://doi.org/10.1182/blood-2011-04-347575

Published: 2011

Journal Articles

Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07

Blood (2010) 116 (21): 2131.

https://doi.org/10.1182/blood.V116.21.2131.2131

Published: 2010

Journal Articles

Health-Related Quality of Life In Patients with Chronic Myeloid Leukemia Undergoing First Line Treatment with Imatinib for at Least Three Years Compared with the General Population. A Multicenter Study Including 448 Patients

Blood (2010) 116 (21): 2273.

https://doi.org/10.1182/blood.V116.21.2273.2273

Published: 2010

Journal Articles

Improved Clinical Outcome of Adult Patients with Ph+ ALL After a Combined Imatinib-Chemotherapy Induction/Consolidation Program Followed by Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Prospective Study of the Northern Italy Leukemia Group

Blood (2010) 116 (21): 682.

https://doi.org/10.1182/blood.V116.21.682.682

Published: 2010

Journal Articles

New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia

Francesco Onida, MD, Cinzia Scavullo, MS, Federica Servida, MS, Giorgia Saporiti, MD, Pierfausto Seneci, D., Chem., Gianluigi Reda, MD, Wilma Barcellini, MD, Agostino Cortelezzi, Domenico Delia, PhD, Giorgio Lambertenghi Deliliers, MD

Blood (2010) 116 (21): 1835.

https://doi.org/10.1182/blood.V116.21.1835.1835

Published: 2010

Journal Articles

Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included In the Prospective O-CLL1 GISL Study.

Blood (2010) 116 (21): 4613.

https://doi.org/10.1182/blood.V116.21.4613.4613

Published: 2010

Journal Articles

Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial

Blood (2010) 116 (21): 1360.

https://doi.org/10.1182/blood.V116.21.1360.1360

Published: 2010

Journal Articles

A Phase II Study of Chlorambucil Plus Rituximab Followed by Maintenance Versus Observation In Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results of the First Interim Analysis

Blood (2010) 116 (21): 2462.

https://doi.org/10.1182/blood.V116.21.2462.2462

Published: 2010

Journal Articles

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Francesco Maura, Giovanna Cutrona, PhD, Massimo Gentile, Serena Matis, PhD, Monica Colombo, Luca Agnelli, Giacomo Tuana, Rosanna Massara, Fabrizio Loiacono, Simona Pedemonte, Daniele Reverberi, Emanuela Anna Pesce, Marta Lionetti, PhD, Sonia Fabris, PhD, Anna Grazia Recchia, Francesco Di Raimondo, MD, Caterina Musolino, MD, Marco Gobbi, Nicola Di Renzo, MD, Francesca Romana Mauro, Renato Cantaffa, Maura Brugiatelli, MD, Francesco Merli, MD, Simonetta Zupo, Caterina Mammi, Luca Baldini, Francesco Angrilli, MD, Gianni Quintana, Ugo Consoli, MD, Giovanni Bertoldero, MD, Emilio Iannitto, MD, Paolo Di Tonno, Antonio Fragasso, Stefano Molica, MD, Pellegrino Musto, MD, Maria Cristina Cox, Gianluca Festini, Vincenzo Callea, MD, Stefano Sacchi, Giorgio Lambertenghi Deliliers, MD, Robin Foà, MD, Massimo Federico, MD, Agostino Cortelezzi, MD, Fortunato Morabito, Manlio Ferrarini, Antonino Neri, MD

Blood (2010) 116 (21): 2423.

https://doi.org/10.1182/blood.V116.21.2423.2423

Published: 2010

Journal Articles

Clinical Relevance of Vascular Endothelial Growth Factor In Myelodysplastic Syndromes

Nicola S. Fracchiolla, aleria Ferla, V, Umberto Gianelli, Claudia Vener, Federica Savi, Gianluigi Reda, Kathrin Aprile von Hohenstaufen Puoti, Giuseppe Gritti, Giorgio Lambertenghi Deliliers, MD, Agostino Cortelezzi

Blood (2010) 116 (21): 4030.

https://doi.org/10.1182/blood.V116.21.4030.4030

Published: 2010

Journal Articles

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

Marta Lionetti, Marta Biasiolo, Luca Agnelli, Katia Todoerti, Laura Mosca, Sonia Fabris, Gabriele Sales, Giorgio Lambertenghi Deliliers, Silvio Bicciato, Luigia Lombardi, Stefania Bortoluzzi, Antonino Neri

Blood (2009) 114 (25): e20–e26.

https://doi.org/10.1182/blood-2009-08-237495

Published: 2009

Includes: Supplemental data

Journal Articles

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Andrea Ferrario, MD, Lilla Cro, PhD, Nadia Zucal, Marta Lionetti, PhD, Francesco Bertoni, MD, Lucia Nobili, PhD, Sonia Fabris, PhD, Katia Todoerti, PhD, Fortunato Morabito, MD, Giovanna Cutrona, PhD, Agostino Cortelezzi, MD, Andrea Guffanti, MD, Maria Cecilia Goldaniga, MD, Stefano Luminari, MD, Luigi Marcheselli, PhD, Manlio Ferrarini, MD, Antonino Neri, MD, Giorgio Lambertenghi Deliliers, MD, Luca Baldini, MD

Blood (2009) 114 (22): 1259.

https://doi.org/10.1182/blood.V114.22.1259.1259

Published: 2009

Journal Articles

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Blood (2009) 114 (22): 2375.

https://doi.org/10.1182/blood.V114.22.2375.2375

Published: 2009

Journal Articles

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study.

Blood (2009) 114 (22): 2341.

https://doi.org/10.1182/blood.V114.22.2341.2341

Published: 2009

NARROW

Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial)

Salvage Therapy with Bortezomib and Dexamethasone in Elderly Patients with Relapsed Refractory Multiple Myeloma

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Fatigue Is the Major Aspect Compromising Health-Related Quality of Life of Chronic Myeloid Leukemia Patients Receiving Long-Term Imatinib Therapy

Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Patients in Early Stage Disease,

Investigating Personal and Treatment Related Factors Associated with Adherence Behavior in Patients with Chronic Myeloid Leukemia Receiving Long Term Imatinib Therapy

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07

Health-Related Quality of Life In Patients with Chronic Myeloid Leukemia Undergoing First Line Treatment with Imatinib for at Least Three Years Compared with the General Population. A Multicenter Study Including 448 Patients

Improved Clinical Outcome of Adult Patients with Ph+ ALL After a Combined Imatinib-Chemotherapy Induction/Consolidation Program Followed by Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Prospective Study of the Northern Italy Leukemia Group

New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia

Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included In the Prospective O-CLL1 GISL Study.

Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial

A Phase II Study of Chlorambucil Plus Rituximab Followed by Maintenance Versus Observation In Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results of the First Interim Analysis

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Clinical Relevance of Vascular Endothelial Growth Factor In Myelodysplastic Syndromes

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only